Skip to content

Clinical trials

Withdrawn Observational Lymphoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma Phase: Observational Status: Withdrawn Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20062
20071
20082
20121
20131
20141
20151
20172

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center2
Mayo Clinic2
Case Comprehensive Cancer Center1
Centre Hospitalier Universitaire, Amiens1
Hamad Medical Corporation1
Massachusetts General Hospital1
National Institute of Allergy and Infectious Diseases (NIAID)1
Rambam Health Care Campus1
Rutgers, The State University of New Jersey1
University of Colorado, Denver1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma13
Precursor Cell Lymphoblastic Leukemia-Lymphoma5
Congenital Abnormalities4
Hodgkin Disease4
Leukemia4
Leukemia, Myeloid, Acute4
Lymphoma, Mantle-Cell4
Lymphoma, Non-Hodgkin4
Burkitt Lymphoma3
Leukemia, Hairy Cell3

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.